Aditxt (ADTX) had the highest return between July 1, 2023 and September 30, 2023 by a US stock, returning 2,675.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Aditxt (ADTX) | 7/1/2023 - 9/30/2023 | 2,675.56% |
Urgently Inc Common Stock (ULY) | 7/1/2023 - 9/30/2023 | 874.39% |
Renovaro Biosciences (RENB) | 7/1/2023 - 9/30/2023 | 718.38% |
Soleno Therapeutics (SLNO) | 7/1/2023 - 9/30/2023 | 604.3% |
error (ZVZZT) | 7/1/2023 - 9/30/2023 | 556.39% |
Femasys (FEMY) | 7/1/2023 - 9/30/2023 | 441.82% |
Taysha Gene Therapies (TSHA) | 7/1/2023 - 9/30/2023 | 371.64% |
Farmmi (FAMI) | 7/1/2023 - 9/30/2023 | 294.29% |
Antelope Enterprise (AEHL) | 7/1/2023 - 9/30/2023 | 260.55% |
Safety Shot (SHOT) | 7/1/2023 - 9/30/2023 | 247.67% |
Tango Therapeutics (TNGX) | 7/1/2023 - 9/30/2023 | 241.21% |
Oncology Institute (TOIIW) | 7/1/2023 - 9/30/2023 | 229.39% |
Abpro (ABPWW) | 7/1/2023 - 9/30/2023 | 210.08% |
Akso Health Group ADR (AHG) | 7/1/2023 - 9/30/2023 | 204.76% |
SHF (SHFSW) | 7/1/2023 - 9/30/2023 | 195.12% |
VistaGen Therapeutics (VTGN) | 7/1/2023 - 9/30/2023 | 186.34% |
Foxx Development (FOXXW) | 7/1/2023 - 9/30/2023 | 176% |
Cardlytics (CDLX) | 7/1/2023 - 9/30/2023 | 160.66% |
Groupon (GRPN) | 7/1/2023 - 9/30/2023 | 160.54% |
Armata Pharmaceuticals (ARMP) | 7/1/2023 - 9/30/2023 | 158.62% |
GeneDx (WGSWW) | 7/1/2023 - 9/30/2023 | 155.56% |
Performance Shipping (PSHG) | 7/1/2023 - 9/30/2023 | 149.37% |
Helport AI Limited Warrants (HPAIW) | 7/1/2023 - 9/30/2023 | 147.6% |
Universe Pharmaceuticals (UPC) | 7/1/2023 - 9/30/2023 | 147.4% |
United States Cellular (USM) | 7/1/2023 - 9/30/2023 | 145.12% |
